Literature DB >> 22770843

Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptoms.

Regina T Martuscello1, Robert N Spengler, Adela C Bonoiu, Bruce A Davidson, Jadwiga Helinski, Hong Ding, Supriya Mahajan, Rajiv Kumar, Earl J Bergey, Paul R Knight, Paras N Prasad, Tracey A Ignatowski.   

Abstract

The manifestation of chronic, neuropathic pain includes elevated levels of the cytokine tumor necrosis factor-alpha (TNF). Previously, we have shown that the hippocampus, an area of the brain most notable for its role in learning and memory formation, plays a fundamental role in pain sensation. Using an animal model of peripheral neuropathic pain, we have demonstrated that intracerebroventricular infusion of a TNF antibody adjacent to the hippocampus completely alleviated pain. Furthermore, intracerebroventricular infusion of rTNF adjacent to the hippocampus induced pain behavior in naïve animals similar to that expressed during a model of neuropathic pain. These data support our premise that enhanced production of hippocampal-TNF is integral in pain sensation. In the present study, TNF gene expression was induced exclusively in the hippocampus, eliciting increased local bioactive TNF levels, and animals were assessed for pain behaviors. Male Sprague-Dawley rats received stereotaxic injection of gold nanorod (GNR)-complexed cDNA (control or TNF) plasmids (nanoplasmidexes), and pain responses (i.e., thermal hyperalgesia and mechanical allodynia) were measured. Animals receiving hippocampal microinjection of TNF nanoplasmidexes developed thermal hyperalgesia bilaterally. Sensitivity to mechanical stimulation also developed bilaterally in the rat hind paws. In support of these behavioral findings, immunoreactive staining for TNF, bioactive levels of TNF, and levels of TNF mRNA per polymerase chain reaction analysis were assessed in several brain regions and found to be increased only in the hippocampus. These findings indicate that the specific elevation of TNF in the hippocampus is not a consequence of pain, but in fact induces these behaviors/symptoms.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22770843      PMCID: PMC3417838          DOI: 10.1016/j.pain.2012.05.028

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  19 in total

Review 1.  Neuroinflammation and comorbidity of pain and depression.

Authors:  A K Walker; A Kavelaars; C J Heijnen; R Dantzer
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

2.  Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling.

Authors:  Anna Dellarole; Paul Morton; Roberta Brambilla; Winston Walters; Spencer Summers; Danielle Bernardes; Mariagrazia Grilli; John R Bethea
Journal:  Brain Behav Immun       Date:  2014-06-02       Impact factor: 7.217

3.  ISSLS PRIZE IN CLINICAL SCIENCE 2018: longitudinal analysis of inflammatory, psychological, and sleep-related factors following an acute low back pain episode-the good, the bad, and the ugly.

Authors:  David M Klyne; Mary F Barbe; Wolbert van den Hoorn; Paul W Hodges
Journal:  Eur Spine J       Date:  2018-02-19       Impact factor: 3.134

4.  [Hippocampus is involved in 17β-estradiol exacerbating experimental occlusal inter- ference-induced chronic masseter hyperalgesia in ovariectomized rats].

Authors:  Y Y Fan; Y Liu; Y Cao; Q F Xie
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18

5.  The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice.

Authors:  Muzaffar Abbas; Sami Alzarea; Roger L Papke; Shafiqur Rahman
Journal:  Pharmacol Rep       Date:  2019-07-03       Impact factor: 3.024

6.  Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell.

Authors:  Xiao-Bo Wu; Peng-Bo Jing; Zhi-Jun Zhang; De-Li Cao; Ming-Hui Gao; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Neuropsychopharmacology       Date:  2018-06-11       Impact factor: 7.853

7.  Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factor.

Authors:  Elizabeth Gerard; Robert N Spengler; Adela C Bonoiu; Supriya D Mahajan; Bruce A Davidson; Hong Ding; Rajiv Kumar; Paras N Prasad; Paul R Knight; Tracey A Ignatowski
Journal:  Pain       Date:  2015-07       Impact factor: 7.926

8.  Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice.

Authors:  Rajasa Randhi; Melissa Damon; Kirsty J Dixon
Journal:  BMC Gastroenterol       Date:  2021-05-28       Impact factor: 3.067

9.  Underweight and obesity are strong predictors of clinical outcomes in patients with ankylosing spondylitis: data from the Smart-phone SpondyloArthritis Management System.

Authors:  Lidong Hu; Xiaojian Ji; Yiwen Wang; Siliang Man; Xingkang Liu; Lei Wang; Jian Zhu; Jidong Cheng; Feng Huang
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-13       Impact factor: 5.346

10.  Completing the Pain Circuit: Recent Advances in Imaging Pain and Inflammation beyond the Central Nervous System.

Authors:  Clas Linnman; David Borsook
Journal:  Rambam Maimonides Med J       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.